MEDVi vs Ro vs PlexusDx for cash-pay GLP-1 weight loss: real annualized cost math, compounded vs FDA-approved branded, safety considerations, and where genetic baselining changes the dose decision before week one.

MEDVi vs Hers vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication source, tirzepatide availability across all three, cancellation and refund policy differences, and where the Precision Peptide Genetic Test fits when GLP-1 response varies by GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants.

MEDVi sells two different oral GLP-1 products under one banner: a compounded semaglutide tablet from $249/month and a Wegovy pill route at $99/month membership plus medication. We unpack the pricing, the FDA regulatory status, the 72-hour cancellation rule, and where PlexusDx Semaglutide Oral ($209/mo+) and Microdose GLP-1 Protocol ($129/mo flat) fit for cash-pay readers who want a non-injection GLP-1.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.

Constipation is one of the most common GLP-1 side effects — here's the food, fluid, movement, and dose-adjustment playbook that actually works, plus where the PlexusDx Microdose GLP-1 Protocol and Precision Peptide Genetic Test fit in.

What's common, what's serious, and how to manage GLP-1 side effects from FDA-labeled known information — including the boxed warning that applies to both semaglutide and tirzepatide, when to call your provider, and how PlexusDx structures titration and the optional Precision Peptide Genetic Test.

The honest list of GLP-1 options under $200/mo in April 2026 is much shorter than the ads suggest. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest under-$200 option in this comparison, with PlexusDx Semaglutide Injection at $179/mo entry tier as the lowest weekly compounded semaglutide path. FDA-approved Foundayo and the Wegovy pill start at $149/mo at lower doses but escalate with dose; most other “$199 GLP-1” ads are first-month-only promos that jump to $249–$349 on refill.

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth. Kentucky Medicaid does not cover GLP-1 for weight loss. PlexusDx Weight Management Protocols ship to all 120 Kentucky counties from $129/mo flat with no membership fee.

The full 2026 GLP-1 cost map: Wegovy, Ozempic, Zepbound, and Mounjaro at branded list price; Lilly Direct and NovoCare manufacturer self-pay programs ($149–$499/mo); cash-pay compounded telehealth alternatives. PlexusDx Weight Management Protocols span $129–$509/mo with all-inclusive pricing, no membership, all 50 states.

Eden semaglutide reviews reveal flat-dose pricing strengths, BBB complaint friction, and four published price points across Eden's own pages. Compare Eden's compounded semaglutide with PlexusDx Semaglutide Injection ($179–$229/mo), Microdose GLP-1 ($129/mo flat), and Semaglutide Oral (from $209/mo) — cash-pay, no membership, with optional genetic-test dose personalization.

Eden vs Ro vs PlexusDx for cash-pay GLP-1 weight loss in 2026: real annualized cost math on Eden’s $129–$329/mo all-inclusive compounded plans, Ro’s $149/mo membership plus FDA-approved branded medication (Wegovy, Zepbound, Ozempic, Foundayo), and PlexusDx Weight Management Protocols from $129/mo — with the Precision Peptide Genetic Test as a $99 add-on so dosing is anchored to GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants before week one.

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $179–$229/mo.

How PlexusDx Weight Management Protocols compare to the major cash-pay GLP-1 programs in 2026 — Mochi, Eden, MEDVi, Ro, GoodRx Care Direct, NovoCare, and LillyDirect — on price, medication source, membership fees, and total annualized cost.

Are GLP-1 pills safe? Four are FDA-approved in 2026 (Rybelsus, Ozempic tablets, Wegovy tablet, Foundayo). Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category. No-prescription drops and gummies aren't legitimate. Here's the safety framework, the boxed-warning context, and where PlexusDx oral protocols fit.

A buyer-side read of the seven brand-name GLP-1 telehealth providers (Ro, Walgreens, GoodRx, Hims & Hers, PlushCare, Sesame, WeightWatchers) covering true month-one cost, what each dispenses, and how PlexusDx compounded protocols ($129–$325/mo, all-inclusive, no membership) fit when branded coverage isn't accessible.

Wegovy oral options as of April 2026: this article explains what formats are FDA-approved, how oral and injection forms compare on bioavailability and dosing, what administration requires, and the PlexusDx Weight Management Protocols that offer both oral and injection options.

Wegovy oral options as of April 2026: this article explains what formats are FDA-approved, how oral and injection forms compare on bioavailability and dosing, what administration requires, and the PlexusDx Weight Management Protocols that offer both oral and injection options.

Wegovy 25 mg is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the 25 mg dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

Wegovy 0.25 mg is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the 0.25 mg dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.

Wegovy overview: this article covers what it is, how it works mechanically, FDA-approved indications, common and serious side effects including the class boxed-warning context, April 2026 cost landscape, and the FTO, GLP1R, MC4R, and TCF7L2 variants that shape every GLP-1 response.

Wegovy is a GLP-1 pathway compound relevant to dietary support through its effects on appetite, satiety, and metabolism. This article covers mechanism, clinical trial evidence, FDA-approved indications, boxed-warning safety, and the FTO, GLP1R, MC4R, and TCF7L2 variants that shape every GLP-1 response.

Wegovy 2.4 mg is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the 2.4 mg dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

Wegovy is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

No FDA-approved generic Wegovy exists as of April 2026. This article explains why (patent exclusivity and the biosimilar pathway), what "generic Wegovy" typically means in consumer search, legitimate compounded alternatives through licensed pharmacies, and PlexusDx Weight Management Protocols as a published-price option.

No FDA-approved generic Wegovy exists as of April 2026. This article explains why (patent exclusivity and the biosimilar pathway), what "generic Wegovy" typically means in consumer search, legitimate compounded alternatives through licensed pharmacies, and PlexusDx Weight Management Protocols as a published-price option.

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.

Wegovy is a subcutaneous injection per the FDA-approved label, given in the abdomen, thigh, or upper arm with rotation within the chosen area. This article reports the label factually — including what to avoid, when to contact a provider, and how PlexusDx protocols include injection training.

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.